Clinuvel Pharmaceuticals Ltd (CLVLF) stock

CLVLFOTCAmerican Depositary ReceiptsFiscal year ends June 30Also trades as CUVL

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 30, 2026Score 9/30

$5.05−0.33 (-6.13%)

Close on Oct 19, 2026Market cap $254.66MP/E 11.0Yield –

Clinuvel Pharmaceuticals price to free cash flow

Price to free cash flow is market cap divided by free cash flow over the trailing twelve months.

Clinuvel Pharmaceuticals's price to free cash flow was 21.6× on Nov 3, 2026, against 13.4× a year earlier. Over the last 2 years it ranged from 11.1× to 25.4×, with a median of 18.0×.

Price to Free Cash Flow at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 3, 2026	21.6×	+5.9
2025	Dec 31, 2025	15.7×	−3.9
2024	Dec 31, 2024	19.5×	–

Where these numbers come from

Parsed from the XBRL in Clinuvel Pharmaceuticals's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing